Colgate-Palmolive Company (CL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 654,000 | 555,000 | 561,000 | 600,000 | 847,000 |
Receivables | 1,690,000 | 1,594,000 | 1,709,000 | 1,626,000 | 1,780,000 |
Inventories | 1,278,000 | 1,246,000 | 1,259,000 | 1,209,000 | 1,241,000 |
Other current assets | 469,000 | 416,000 | 402,000 | 375,000 | 336,000 |
TOTAL | $4,091,000 | $3,811,000 | $3,931,000 | $3,810,000 | $4,204,000 |
Non-Current Assets | |||||
PPE Net | 3,572,000 | 3,410,000 | 3,466,000 | 3,516,000 | 3,351,000 |
Intangibles | 3,154,000 | 3,003,000 | 3,065,000 | 3,123,000 | 3,122,000 |
Other Non-Current Assets | 573,000 | 362,000 | 361,000 | 685,000 | 390,000 |
TOTAL | $7,299,000 | $6,775,000 | $6,892,000 | $7,324,000 | $6,863,000 |
Total Assets | $11,390,000 | $10,586,000 | $10,823,000 | $11,134,000 | $11,067,000 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 8,000 | 8,000 | 320,000 | 326,000 | 318,000 |
Accounts payable and accrued liabilities | 1,096,000 | 1,105,000 | 1,129,000 | 1,172,000 | 1,084,000 |
TOTAL | $3,176,000 | $2,955,000 | $3,818,000 | $3,599,000 | $3,591,000 |
Non-Current Liabilities | |||||
Long Term Debt | 3,329,000 | 3,331,000 | 2,755,000 | 2,821,000 | 2,883,000 |
Other Non-Current Liabilities | 1,901,000 | 1,304,000 | 1,332,000 | 1,350,000 | 1,330,000 |
TOTAL | $5,368,000 | $4,827,000 | $4,241,000 | $4,278,000 | $4,365,000 |
Total Liabilities | $8,544,000 | $7,782,000 | $8,059,000 | $7,877,000 | $7,956,000 |
Shareholders' Equity | |||||
Shares Outstanding, K | 965,367 | 971,998 | 980,907 | 987,494 | 994,382 |
Common Shares | 733,000 | 733,000 | 733,000 | 733,000 | 733,000 |
Retained earnings | 13,980,000 | 13,622,000 | 13,032,000 | 13,157,000 | 12,761,000 |
Other shareholders' equity | -2,234,000 | -2,225,000 | -2,074,000 | -2,088,000 | -2,105,000 |
TOTAL | $2,846,000 | $2,804,000 | $2,764,000 | $3,257,000 | $3,111,000 |
Total Liabilities And Equity | $11,390,000 | $10,586,000 | $10,823,000 | $11,134,000 | $11,067,000 |